Re:Opaque drug pricing in the U.S.
by jt2190 on Sunday March 12, 2017 @04:55PM
(#13853052)
You haven't explained why 10% of total healthcare costs should not be subject to price transparency.
[ Parent
| on HN ]
There are no comments on this comment yet.